ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Metastases, Neoplasm
Interventions: DRUG: ABI-007
Sponsor: Celgene Corporation